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Abstract
Production of antimicrobial peptides in plants constitutes an approach for obtaining them in high amounts. However,
their heterologous expression in a practical and efficient manner demands some structural requirements such as a
minimum size, the incorporation of retention signals to assure their accumulation in specific tissues, and the
presence of protease cleavage amino acids and of target sequences to facilitate peptide detection. Since any
sequence modification may influence the biological activity, peptides that will be obtained from the expression must
be screened prior to the synthesis of the genes for plant transformation. We report herein a strategy for the
modification of the antimicrobial undecapeptide BP100 that allowed the identification of analogues that can be
expressed in plants and exhibit optimum biological properties. We prepared 40 analogues obtained by incorporating
repeated units of the antimicrobial undecapeptide, fragments of natural peptides, one or two AGPA hinges, a Gly or
Ser residue at the N-terminus, and a KDEL fragment and/or the epitope tag54 at the C-terminus. Their antimicrobial,
hemolytic and phytotoxic activities, and protease susceptibility were evaluated. Best sequences contained a
magainin fragment linked to the antimicrobial undecapeptide through an AGPA hinge. Moreover, since the presence
of a KDEL unit or of tag54 did not influence significantly the biological activity, these moieties can be introduced when
designing compounds to be retained in the endoplasmic reticulum and detected using a complementary epitope.
These findings may contribute to the design of peptides to be expressed in plants.
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Introduction
Antimicrobial peptides (AMPs) are short sequences
containing less than 50 amino acids. They are considered a
first line of defense in plants and animals or are produced by
microorganisms participating in antibiosis processes [1]. There
is broad literature review on AMPs produced in bacteria [2-4],
fungi [5,6], insects [7,8], marine invertebrates [9], amphibian,
mammals [10,11], and plants [12].
Due to their potential high biocompatibility, moderate
biodegradability, and low resistance developed on target
microorganisms, AMPs offer great perspectives as a novel
class of antibiotics with application in several fields. They can
be used to combat fungal and bacterial infections in humans
[7,10] and plant diseases in crop protection [1,13,14].
Moreover, they can substitute or complement antibiotics in
animal feed, biopreservatives in food, cosmetics and
biomaterials, and antifoulings [15,16]. However, the exploitation
of AMPs encounters several difficulties because they are
produced at low concentrations in living organisms and often
their antimicrobial activity is low to moderate. In addition, some
of the AMPs showing high antimicrobial activity may be
relatively toxic to non-target organisms (animals, humans,
plants).
To overcome the above limitations, novel peptides have
been designed based on structure-activity relationship studies
in natural AMPs. Small truncated sequences containing the
minimal domain for activity have been developed as well as
chimeric constructions. De novo designed sequences, bearing
structural features that are crucial for the activity of natural
peptides, have also been reported. Combinatorial chemistry
approaches are also powerful tools that have been used to
optimize the biological activity profile of AMPs, and sequences
with improved activity, decreased toxicity to non-target
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organisms and low susceptibility to proteolytic hydrolysis have
been identified. Following this rationale, we have designed
chimeric peptides that are cecropin A-melittin hybrids and their
biological activity has been optimized through the synthesis of
a 125-member library (CECMEL11) [17]. From this library we
have identified BP100 and several analogues active against
bacterial and fungal phytopathogens with minimal inhibitory
concentrations (MIC) lower than 10 μM [17-19]. This activity is
relevant because it is of the same order than that of standard
antibiotics and antifungals (e.g. penicillins, aminoglycosides,
ketoconazole). Moreover, they showed an extremely high
biocompatibility with an acute oral toxicity, determined as the
LOD50, higher than 2000 mg/Kg of body weight in mice [20].
BP100 and its derivatives have strong cationic charge and
amphipathic arrangement that enable their interaction with
biological membranes resulting in cell membrane disruption.
Biophysical studies with BP100 using phospholipid bilayers
similar to that of the bacterial cytoplasmic membrane showed
vesicle permeabilization, membrane electroneutrality, and
vesicle aggregation, but also translocation [21]. It has been
also reported that BP100 is a fast and efficient cell-penetrating
agent to deliver functional cargoes peptides into tobacco cells
[22].
Exploitation of AMPs may be performed by expression in
plants for self-defence against bacterial or fungal pathogens or
through mass production to be used as active ingredients in
antimicrobial formulations. Mass production can be
accomplished through chemical or quimioenzymatic synthesis,
or by means of microbial or plant biofactories. Chemical
synthesis using solution or solid-phase protocols or employing
enzymatic procedures is only economically feasible for the
preparation of short peptides. In contrast, heterologous
production of AMPs using living systems as biofactories offers
a reliable and sustainable mean of exploitation of these
peptides which can lead to high amounts of product. Microbial
systems, such as Escherichia coli or Pichia pastoris, have been
reported as efficient production platforms for several proteins
[23,24]. Plants have also been used as biofactories for the
production of medium to large size proteins due to their high
added value for pharmaceutical applications [25-28].
Linear AMPs containing proteinogenic aminoacids can also
be produced in plants [13,29]. However, to be heterologous
expressed in plants, peptides must fulfill some structural
requirements. Particularly, the size of the peptide has to be
above a minimum expressability threshold [30]. Moreover, the
peptide has to be targeted to subcellular organelles to
guarantee its stability and avoid cell toxicity [31]. In addition,
the expression and accumulation of the peptide in specific plant
tissues is necessary to meet low cost production needs [32]
and to decrease downstream processing operations [33,34]. To
accomplish these requirements the following strategies may be
used: (i) increase of the peptide length by n-merizations,
chimeric enlargements or fusions [35], (ii) stabilization/
distortion by incorporating an AGPA hinge between the peptide
fragments [36], (iii) introduction of retention signals for the
accumulation of peptides in subcellular organelles, such as the
endoplasmic reticulum by the addition of the KDEL sequence
at the C-terminus [13,37], (iv) incorporation of protease
cleavage amino acids for processing fusions [38], and (v) of
target sequences to allow peptide detection and/or purification
[39,40].
Taking into account these considerations, to achieve an
efficient production of the CECMEL11 peptides in living
systems and, particularly, in plants, the sequences to be
expressed should incorporate the above structural features.
Unfortunately, any sequence modification may have dramatical
consequences in the peptide properties, including
antimicrobial, hemolytic and phytotoxic activities as well as
protease susceptibility, as it has been previously described
[17,19,20]. Therefore, the biological activity of the sequences
that will be obtained from the expression process must be
screened prior to the synthesis of the corresponding genes and
the cloning systems for plant transformation.
In the present work, we designed, synthesized and evaluated
40 sequences derived from BP100 for their antimicrobial,
hemolytic and phytotoxic activities, and protease susceptibility.
These analogues were designed based on the structural
requirements that they must possess to be expressed in plants.
Finally, the best candidates are proposed for further
development of transgenic plants for their production.
Materials and Methods
Peptide synthesis
All peptides were synthesized manually by the solid-phase
method using 9-fluorenylmethoxycarbonyl (Fmoc)-type
chemistry, tert-butyloxycarbonyl side-chain protection for Lys
and Trp, tert-butyl (tBu) for Tyr, Glu, Asp, Thr, Gln and Ser, and
trityl for His. An aminomethyl ChemMatrix resin (0.59 mmol/g)
was used as solid support. The linker 3-(4-
hydroxymethylphenoxy)propionic acid (PAC) was employed to
obtain C-terminal peptide acids. The PAC linker (3 equiv) was
coupled to the resin with N-[1H-benzotriazol-1-yl)
(dimethylamino)methylene]-N-methylmethanaminium
hexafluorophosphate N-oxide (HBTU) (3 equiv) and N,N-
diisopropylethylamine (DIEA) (3 equiv) in N,N-
dimethylformamide (DMF) for 5 h, and the reaction was
monitored by the ninhydrin test. The coupling of the first amino
acid (5 equiv) was performed using N,N-
diisopropylcarbodiimide (DIPCDI) (5 equiv), 1-
hydroxybenzotriazole (HOBt) (5 equiv) and N,N-
dimethylaminopyridine (DMAP) (1.25 equiv) in DMF for 15 h.
After the coupling, an Fmoc test was performed to check the
resin loading. The resin was then acylated by treatment with a
mixture of acetic anhydride−pyridine−CH2Cl2 (1:1:1; 2 × 30
min). Couplings of the other Fmoc-amino acids (4 equiv) were
mediated by HBTU (3.8 equiv), HOBt (4 equiv) and DIEA (7.8
equiv) in DMF for 1 h, and monitored by the ninhydrin test.
Fmoc group was removed by treating the resin with a mixture
of piperidine−DMF (3:7; 2 + 10 min). Peptides were individually
cleaved from the resin with trifluoroacetic acid (TFA)-H2O
−triisopropylsilane (95:2.5:2.5; 2 h). Following TFA evaporation
and diethyl ether extraction, the crude peptides were dissolved
in H2O and lyophilized.
Peptides were analyzed under standard analytical high-
performance liquid chromatography (HPLC) conditions with a
Peptides for Expression in Plants
PLOS ONE | www.plosone.org 2 December 2013 | Volume 8 | Issue 12 | e85515
Dionex liquid chromatography instrument (Conditions A-D).
Detection was performed at 220 nm. Solvent A was 0.1%
aqueous TFA and solvent B was 0.1% TFA in CH3CN.
Conditions A: Analysis was carried out with a Kromasil 100 C18
(4.6 mm × 40 mm, 3.5 μm) column with a 2–100% B over 7 min
at a flow rate of 1 ml/min. Conditions B: Analysis was carried
out with a Kromasil 100 C18 (4.6 mm × 40 mm, 3.5 μm) column
with a 30–50% B over 6 min at a flow rate of 1 ml/min.
Conditions C: Analysis was carried out with a Kromasil 100 C18
(4.6 mm × 40 mm, 3.5 μm) column with a 60–70% B over 6 min
at a flow rate of 1 ml/min. Conditions D: Analysis was carried
out with a Kromasil 100 C18 (4.6 mm × 250 mm, 3.5 μm)
column with a 2–100% B over 30 min at a flow rate of 1 ml/min.
Other peptides were analyzed under standard analytical HPLC
conditions with an Agilent Technologies 1200 Series liquid
chromatography instrument (Conditions E). Detection was
performed at 220 nm. Solvent A was 0.1% aqueous TFA and
solvent B was 0.1% TFA in CH3CN. Conditions E: Analysis was
carried out with a Kromasil 100 C18 (4.6 mm × 40 mm, 3.5 μm)
column with a 2–100% B over 5 min at a flow rate of 1 ml/min.
Electrospray ionization mass spectrometry (ESI-MS, Bruker
Daltonics, USA) and matrix-assisted laser desorption ionization
with time-of-flight analysis (MALDI-TOF, Bruker, USA) were
used to confirm peptide identity.
Peptides BP216, BP217, BP235 and BP236 were
purchased from CASLO Laboratory ApS (Lyngby, Denmark) at
>90% purity.
Bacterial strains and growth conditions
For the analysis of the in vitro activity of peptides, the
following plant pathogenic bacterial strains were used: E.
amylovora PMV6076 (Institut National de la Recherche
Agronomique, Angers, France), P. syringae pv. syringae
EPS94 (Institut de Tecnologia Agroalimentària, Universitat de
Girona, Spain) and X. axonopodis pv. vesicatoria 2133-2
(Instituto Valenciano de Investigaciones Agrarias, Valencia,
Spain). All bacteria were stored in Luria Bertani (LB) broth
supplemented with glycerol (20%) and maintained at -80 °C. All
strains were scrapped from LB agar plates incubated at 25 °C
after growing for 24 h in the case of E. amylovora and P.
syringae pv. syringae, and for 48 h for X. axonopodis pv.
vesicatoria. The cell material was suspended in sterile water to
obtain a suspension of 108 CFU ml-1.
Antibacterial activity
Lyophilized peptides were solubilized in sterile distilled water
to a concentration of 1000 μM and filter sterilized through a
0.22-μm-pore-size filter. For MIC assessment, dilutions of the
synthetic peptides were made to obtain a final concentration of
200, 100, 75, 50, 25 and 12.5 μM. Twenty microlitres of each
dilution were mixed in a microtiter plate well with 20 μl of the
corresponding suspension of the bacterial indicator at 108 CFU
ml-1 and with 160 μl of Trypticase Soy Broth (TSB) (BioMèrieux,
France) to a total volume of 200 μl. Final peptide
concentrations assayed were 20, 10, 7.5, 5, 2.5 and 1.25 μM.
Tag54 and tag54-2 were tested at 100 μM. Three replicates for
each strain, peptide and concentration were used. Positive
controls contained water instead of peptide and negative
controls contained peptide without bacterial suspension.
Microbial growth was automatically determined by optical
density measurement at 600 nm (Bioscreen C, Labsystem,
Finland). Microplates were incubated at 25 °C with 20 s
shaking before hourly absorbance measurement for 48 h. The
experiment was repeated twice. The MIC was taken as the
lowest peptide concentration with no growth at the end of the
experiment.
Hemolytic activity
The hemolytic activity of peptides was evaluated by
determining hemoglobin release from erythrocyte suspensions
of fresh human blood (5%, vol/vol). Blood was aseptically
collected using a BD vacutainer K2E System with EDTA
(Belliver Industrial State, Plymouth, U.K.) and stored for less
than 2 h at 4 °C. Blood was centrifuged at 6,000 × g for 5 min,
washed three times with TRIS buffer (10 mM TRIS, 150 mM
NaCl, pH 7.2) and ten-fold diluted in the same buffer. Peptides
were solubilized in TRIS buffer to a concentration of 500, 300
and 100 μM. Sixty five microliters of human red blood cells
were mixed with 65 μl of the peptide solution (final
concentration of 250, 150 and 50 μM) in a 96-well reaction
plate and incubated under continuous shaking for 1 h at 37 °C.
Then, the plates were centrifuged at 3,500 × g for 10 min.
Eighty microliter aliquots of the supernatant were transferred to
100-well microplates and diluted with 80 μl of sterile distilled
water. Three replicates for each peptide were used. Hemolysis
was measured as the absorbance at 540 nm with a microplate
reader. Complete hemolysis was determined in TRIS buffer
plus melittin at 100 μM as a positive control. The percentage of
hemolysis (H) was calculated using the equation: H = 100 ×
[(Op − Ob)/(Om − Ob)], where Op is the density for a given
peptide concentration, Ob for the buffer, and Om for the melittin
positive control.
Phytotoxicity
A set of 16 selected peptides BP100, BP134, BP173,
BP178, BP183, BP188, BP192, BP209, BP210, BP211,
BP213, BP214, BP215, BP216, BP217 and BP235 were
evaluated for their phytotoxicity. Tobacco plants (Nicotiana
benthamiana) were grown from seed in the glasshouse and
used between 20 and 30 days old. One hundred μl of the
peptides at concentrations from 50 to 250 μM, depending on
the peptide, were inoculated into the mesophylls of tobacco
leaves as described previously [41], and plants were incubated
again for three days. Up to six independent inoculations were
carried out in a single leaf, and at least three independent
inoculations were performed per peptide and concentration,
randomly distributed in different leaves and plants. Toxicity was
measured as the lesion diameter.
Ethics statement
The use of human blood samples was solely to assess the
hemolytic activity of the peptides, and was not used for other
type of research with ethics concerns. The president of the
Research Committee of the University of Girona confirmed that
ethics approval was not required for the collection of blood
samples.
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Results
Design and synthesis of peptides
Peptides were designed and synthesized in order to obtain
sequences with optimized properties for plant expression at
high yield and for accumulation in different subcellular plant cell
compartments. Peptide sequences were based on the
antimicrobial peptide BP134 (KKLFKKILKYL-OH), a C-terminal
carboxylic acid derivative of BP100 [17]. A total of 40 peptides
of 15 to 52 amino acids in length were prepared. One set of
peptides contained one, two or three units of BP134 (Table 1)
and a second set incorporated a combination of one unit of
BP134 with: (i) melittin(10-19) or melittin(1-13); (ii)
magainin(4-10); (iii) magainin(1-10); and (iv) cecropin A(25-37)
(Table 2). Analogues of these peptides were also obtained by
introducing: (i) one or two AGPA hinges as stabilization/
distortion moiety; (ii) a KDEL fragment at the C-terminus as a
signal for permanent retention of peptides in the endoplasmic
reticulum; (iii) a Gly or a Ser residue at the N-terminus as a
TEV protease recognition site; and (iv) the epitope tag
KDWEHLKDWEHLKDWEHL (tag54) at the C-terminus for
peptide detection or purification.
The synthesis was performed following a standard Fmoc/tBu
solid-phase peptide synthesis methodology to yield C-terminal
carboxylic acid sequences; overall purity was among 71-99% ,
except for three sequences that were obtained in 52-68% purity
(Tables 1 and 2). Their molecular weights were confirmed by
mass spectrometry.
Antibacterial activity
The peptides synthesized were tested for in vitro growth
inhibition of X. axonopodis pv. vesicatoria, P. syringae pv.
syringae and E. amylovora at 1.25, 2.5, 5.0, 7.5, 10, and 20 μM
and compared to that of BP134 (Tables 3 and 4).
From the analysis of the first set of peptides incorporating
repeating units of BP134, we observed that the dimer BP203
displayed higher activity than the trimer BP204 against the
three pathogens (Table 3). Moreover, BP203 was more active
than the monomer BP134 against X. axonopodis pv.
vesicatoria (1.25-2.5 μM vs 10-20 μM) and P. syringae pv.
Table 1. Sequences, number of amino acids, retention times and purities on HPLC, and mass spectrometry data of peptides
from the first set.
Peptide Sequence #Aa  tR (min)a  Purityb (%)  Theoretical monoisotopic m/z  Observed m/zc
BP134 monomers      
BP134 KKLFKKILKYL-OH 11 6.24d 90 1421.9 1422.1 [M+H]+
BP199 KKLFKKILKYL-AGPA-OH 15 6.60d 89 1718.1 1718.3 [M+H]+
BP214 KKLFKKILKYL-KDEL-OH 15 3.14e 88 1907.2 1907.2 [M+H]+
BP134 dimers      
BP203 KKLFKKILKYL-KKLFKKILKYL-OH 22 7.48d 85 2824.9 2824.9 [M+H]+
BP202 KKLFKKILKYL-AGPA-KKLFKKILKYL-OH 26 3.58e 99 3121.1 3121.3 [M+H]+
BP193 G-KKLFKKILKYL-AGPA-KKLFKKILKYL-OH 27 7.18d 89 3179.1 3178.8 [M+H]+
BP195 S-KKLFKKILKYL-AGPA-KKLFKKILKYL-OH 27 7.19e 93 3209.1 3208.7 [M+H]+
BP200 KKLFKKILKYL-AGPA-KKLFKKILKYL-AGPA-OH 30 7.53e 68 3417.2 3417.4 [M+H]+
BP198 KKLFKKILKYL-KKLFKKILKYL-KDEL-OH 26 4.08e 99 3311.3 3311.5 [M+H]+
BP192 KKLFKKILKYL-AGPA-KKLFKKILKYL-KDEL-OH 30 7.27d 95 3607.5 3608.0 [M+H]+
BP213 KKLFKKILKYL-AGPA-LYKLIKKFLKK-KDEL-OH 30 3.48e 90 3606.3 3606.3 [M+H]+
BP194 G-KKLFKKILKYL-AGPA-KKLFKKILKYL-KDEL-OH 31 7.33d 91 3664.6 3665.0 [M+H]+
BP196 S-KKLFKKILKYL-AGPA-KKLFKKILKYL-KDEL-OH 31 7.35d 71 3694.6 3695.0 [M+H]+
BP236 KKLFKKILKYL-AGPA-KKLFKKILKYL-AGPA-KDWEHLKDWEHLKDWEHL-KDEL-OH 52 20.30
f 99 6330.7 [M+H]+ 1266.9 [M+5H]5+
BP134 trimers      
BP204 KKLFKKILKYL-KKLFKKILKYL-KKLFKKILKYL-OH 33 9.27d 52 4228.8 4229.3 [M+H]+
BP201 KKLFKKILKYL-AGPA-KKLFKKILKYL-AGPA-KKLFKKILKYL-OH 41 8.13d 67 4821.1 4821.4 [M+H]+
BP216 KKLFKKILKYL-AGPA-KKLFKKILKYL-AGPA-KKLFKKILKYL-KDEL-OH 45 4.18e 99 5307.8 [M+H]+ 885.3 [M+6H]6+
Tags      
tag54 KDWEHLKDWEHLKDWEHL-OH 18 2.95e 99 2443.7 2443.2 [M+H]+
tag54‑2 KDWEHLKDWEHLKDWEHL-KDEL-OH 22 2.96e 99 2629.2 2629.5 [M+H]+
a RP-HPLC retention time
b Percentage determined by HPLC at 220 nm from the crude reaction mixture
c All peptides were analyzed by MALDI-TOF except for BP134, BP216, BP236, tag54, and tag54-2 that were analyzed by ESI-MS
d RP-HPLC analysis using conditions A (see Materials and Methods)
e RP-HPLC analysis using conditions E (see Materials and Methods)
f RP-HPLC analysis using conditions D (see Materials and Methods)
doi: 10.1371/journal.pone.0085515.t001
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syringae (5.0-7.5 μM vs 7.5-10 μM). The introduction of an
AGPA moiety as a hinge between two BP134 units afforded
peptides displaying higher activity (compare BP203 and
BP202; BP198 and BP192; BP204 and BP201). In contrast,
the incorporation of an AGPA moiety at the C-terminus of
BP134 or of BP202 led to peptides BP199 and BP200,
respectively, with enhanced or similar activity against X.
axonopodis pv. vesicatoria (2.5-5.0 μM and <1.25 μM), and
with decreased activity against the other two pathogens. When
a KDEL moiety was introduced at the C-terminus of BP134, an
increase of the activity was observed against the three bacteria
(BP214, 1.25-5.0 μM). However, the presence of a KDEL unit
at the C-terminus of a dimer sequence maintained or
decreased the activity, as shown for BP203 vs BP198, BP202
vs BP192, BP193 vs BP194, and BP195 vs BP196. The same
behaviour was observed for the trimer peptides BP201 and
BP216. The incorporation of a Gly or a Ser residue at the N-
terminus of BP192 (5.0-10 μM) and BP202 (<1.25-5.0 μM)
rendered peptides BP193-BP196 with higher MIC values
(7.5-20 μM). The epitope tag peptides tag54 and tag54-2, the
latter incorporating a KDEL unit at the C-terminus, were not
active against the three bacteria. However, the introduction of
tag54-2 into BP200 resulted in peptide BP236 with increased
activity against P. syringae pv. syringae (2.5-5.0 μM) and E.
amylovora (10-20 μM), and with reduced activity against X.
axonopodis pv. vesicatoria (2.5-5.0 μM). Peptide dimer BP213,
bearing a reversed peptide sequence from BP134 at the C-
terminus, was slightly more active than BP192 against the
three pathogens (1.25-5.0 μM vs 5.0-10 μM). From this set of
Table 2. Sequences, number of amino acids, retention times and purities on HPLC, and mass spectrometry data of peptides
from the second set.
Peptide Sequence #Aa  tR (min)a  Purityb (%)  Theoretical monoisotopic m/z  Observed m/zc  
BP134-melittin(10-19) or BP134-melittin(1-13)      
BP170 KKLFKKILKYL-TTGLPALISW-OH 21 6.98d 90 2461.1 2461.4 [M+H]+
BP171 KKLFKKILKYL-AGPA-TTGLPALISW-OH 25 7.13e 87 2757.7 2757.8 [M+H]+
BP207 G-KKLFKKILKYL-AGPA-TTGLPALISW-OH 26 3.41f 85 2814.7 2814.6 [M+H]+
BP208 S-KKLFKKILKYL-AGPA-TTGLPALISW-OH 26 3.41f 85 2844.7 2844.5 [M+H]+
BP172 KKLFKKILKYL-TTGLPALISW-KDEL-OH 25 7.14d 87 2946.8 2946.8 [M+H]+
BP173 KKLFKKILKYL-AGPA-TTGLPALISW-KDEL-OH 29 7.04d 80 3242.9 3243.0 [M+H]+
BP189 KKLFKKILKYL-GIGAVLKVLTTGL-KDEL-OH 28 5.23g 98 3129.9 3130.0 [M+H]+
BP217 KKLFKKILKYL-TTGLPALIS-AGPA-SILAPLGTT-LYKLIKKFLKK-KDEL-OH 48 25.22h 99 5315.7 [M+H]+ 1063.9 [M+5H]5+
BP134-magainin(4-10)      
BP180 KKLFKKILKYL-KFLHSAK-OH 18 6.56d 99 2233.4 2233.4 [M+H]+
BP181 KKLFKKILKYL-AGPA-KFLHSAK-OH 22 6.51d 99 2529.6 2529.6 [M+H]+
BP211 G-KKLFKKILKYL-AGPA-KFLHSAK-OH 23 3.15f 83 2586.6 2586.6 [M+H]+
BP212 S-KKLFKKILKYL-AGPA-KFLHSAK-OH 23 3.16f 82 2616.6 2616.6 [M+H]+
BP182 KKLFKKILKYL-KFLHSAK-KDEL-OH 22 6.13d 99 2718.4 2718.7 [M+H]+
BP183 KKLFKKILKYL-AGPA-KFLHSAK-KDEL-OH 26 6.11d 73 3014.7 3014.8 [M+H]+
BP235 KKLFKKILKYL-AGPA-KFLHSAK-AGPA-KDWEHLKDWEHLKDWEHL-KDEL-OH 48 17.32h 99 5738.8 [M+H]+ 1148.5 [M+5H]5+
BP134-magainin(1-10)      
BP176 KKLFKKILKYL-GIGKFLHSAK-OH 21 6.48d 72 2460.1 2460.3 [M+H]+
BP175 KKLFKKILKYL-AGPA-GIGKFLHSAK-OH 25 6.52e 80 2756.7 2756.7 [M+H]+
BP209 G-KKLFKKILKYL-AGPA-GIGKFLHSAK-OH 26 3.29f 93 2813.7 2813.5 [M+H]+
BP210 S-KKLFKKILKYL-AGPA-GIGKFLHSAK-OH 26 3.30f 92 2843.7 2843.6 [M+H]+
BP179 KKLFKKILKYL-GIGKFLHSAK-KDEL-OH 25 6.44d 99 2945.7 2945.7 [M+H]+
BP178 KKLFKKILKYL-AGPA-GIGKFLHSAK-KDEL-OH 29 6.50d 90 3242.0 3242.7 [M+H]+
BP134-cecropin A(25-37)      
BP188 KKLFKKILKYL-AVAVVGQATQIAK-KDEL-OH 28 5.14g 99 3143.9 3144.0 [M+H]+
BP215 KKLFKKILKYL-AGPA-VAVVGQATQIAK-KDEL-OH 31 3.30f 92 3369.0 3369.0 [M+H]+
BP190 AVAVVGQATQIAK-KKLFKKILKYL-KDEL-OH 28 5.06g 98 3143.9 3144.0 [M+H]+
a RP-HPLC retention time
b Percentage determined by HPLC at 220 nm from the crude reaction mixture
c All peptides were analyzed by MALDI-TOF except for peptides BP217 and BP235 that were analyzed by ESI-MS
d RP-HPLC analysis using conditions A (see Materials and Methods)
e RP-HPLC analysis using conditions B (see Materials and Methods)
f RP-HPLC analysis using conditions E (see Materials and Methods)
g RP-HPLC analysis using conditions C (see Materials and Methods)
h RP-HPLC analysis using conditions D (see Materials and Methods)
doi: 10.1371/journal.pone.0085515.t002
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peptides, the most active sequences were BP202, BP213 and
BP214.
Concerning the second set of peptides, incorporating a
combination of one unit of BP134 with fragments of the natural
antimicrobial peptides melittin, magainin and cecropin A, we
observed that peptide dimers BP170, BP176 and BP180
displayed lower MIC values (1.25-7.5 μM) than BP134 (Table
4). In general, the incorporation of an AGPA moiety into the
sequence of peptides BP170, BP172, BP176, BP179, BP180,
BP182, and BP188 did not significantly influence the activity
rendering peptides BP171, BP173, BP175, BP178, BP181,
BP183 and BP215, respectively, with MIC values of 1.25-10
μM. Sequences BP172, BP173, BP178, BP179, BP182 and
BP183, bearing a KDEL moiety at the C-terminus, were as
active or slightly less active (1.25-10 μM) than the
corresponding peptides BP170, BP171, BP175, BP176,
BP180 and BP181 (1.25-7.5 μM). In general, the derivatization
of BP171, BP175 and BP181 at the N-terminus with a Gly or a
Ser residue resulted in peptides BP207-BP212 with slightly
lower MIC values (<1.25-5.0 μM). Peptide BP235, derived from
BP134 and magainin(4-10) and bearing two AGPA moieties,
tag54-2, and KDEL, showed similar activity than BP181
Table 3. Antibacterial activity (MIC) against three plant
pathogenic bacteria and hemolytic activity of peptides from
the first set.
Peptide  MIC (μM)  Hemolysisb (%)
  Xava Pssa Eaa  50 μM 150 μM 250 μM
BP134 monomers       
BP134  10-20 7.5-10 7.5-10  0 8 18
BP199  2.5-5.0 10-20 10-20  0 0 0
BP214  1.25-2.5 2.5-5.0 2.5-5.0  2 6 9
BP134 dimers       
BP203  1.25-2.5 5.0-7.5 10-20  91 93 95
BP202  <1.25 2.5-5.0 2.5-5.0  83 93 98
BP193  10-20 7.5-10 10-20  62 63 74
BP195  10-20 7.5-10 10-20  71 73 71
BP200  <1.25 7.5-10 >20  79 80 81
BP198  10-20 10-20 10-20  59 72 72
BP192  7.5-10 7.5-10 7.5-10  51 69 69
BP213  1.25-2.5 2.5-5.0 2.5-5.0  90 92 98
BP194  10-20 7.5-10 10-20  71 87 92
BP196  10-20 7.5-10 10-20  61 66 74
BP236  2.5-5.0 2.5-5.0 10-20  49 84 92
BP134 trimers       
BP204  2.5-5.0 10-20 >20  97 100 100
BP201  1.25-2.5 7.5-10 >20  74 81 83
BP216  10-20 >20 >20  89 98 100
Tags         
tag54  >100 >100 >100  0 0 1
tag54-2  >100 >100 >100  0 0 0
aXav, Xanthomonas axonopodis pv. vesicatoria; Pss, Pseudomonas syringae pv.
syringae; Ea, Erwinia amylovora
b Percent hemolysis plus confidence interval (α=0.05)
doi: 10.1371/journal.pone.0085515.t003
 (2.5-5.0 μM). Peptide BP217, which resulted from the
combination of BP170 and a reversed peptide sequence from
BP170 linked with an AGPA moiety and bearing KDEL at the
C-terminus, displayed similar activity than BP170 (<1.25-5.0
μM). The analogue BP172, resulting from the combination of
BP134 and melittin(10-19), was more active (1.25-5.0 μM) than
BP189 bearing a melittin(1-13) fragment. When the BP134 and
cecropin A(25-37) fragments in BP188 (1.25-5.0 μM) were
inverted, the resulting peptide BP190 was poorly active (5.0 -
>20 μM). The best peptides of this second set were BP207,
BP208, BP209, BP210, and BP211 which also displayed
higher activity than the most active peptides from the first set.
Hemolytic activity
The toxicity of peptides to eukaryotic cells was determined
as the ability to lyse erythrocytes in comparison to melittin.
Table 4. Antibacterial activity (MIC) against three plant
pathogenic bacteria and hemolytic activity of peptides from
the second set.
Peptide  MIC (μM)  Hemolysisb (%)
  Xava Pssa Eaa  50 μM 150 μM 250 μM
BP134-melittin(10-19) or BP134-melittin(1-13)     
BP170  1.25-2.5 2.5-5.0 2.5-5.0  82 93 98
BP171  2.5-5.0 1.25-2.5 2.5-5.0  5 16 34
BP207  <1.25 1.25-2.5 1.25-2.5  5 36 58
BP208  <1.25 1.25-2.5 1.25-2.5  15 47 68
BP172  1.25-2.5 2.5-5.0 2.5-5.0  14 49 63
BP173  5.0-7.5 2.5-5.0 5.0-7.5  8 16 40
BP189  2.5-5.0 2.5-5.0 5.0-7.5  41 60 86
BP217  <1.25 2.5-5.0 2.5-5.0  91 100 100
BP134-magainin(4-10)      
BP180  2.5-5.0 2.5-5.0 2.5-5.0  12 54 58
BP181  2.5-5.0 1.25-2.5 2.5-5.0  0 0 0
BP211  <1.25 2.5-5.0 1.25-2.5  0 1 6
BP212  <1.25 2.5-5.0 2.5-5.0  0 5 12
BP182  1.25-2.5 1.25-2.5 2.5-5.0  1 38 59
BP183  5.0-7.5 7.5-10 2.5-5.0  1 4 5
BP235  2.5-5.0 2.5-5.0 2.5-5.0  0 0 0
BP134-magainin(1-10)      
BP176  2.5-5.0 2.5-5.0 5.0-7.5  3 44 59
BP175  1.25-2.5 2.5-5.0 5.0-7.5  6 14 32
BP209  <1.25 2.5-5.0 1.25-2.5  1 13 24
BP210  <1.25 2.5-5.0 1.25-2.5  0 17 30
BP179  2.5-5.0 2.5-5.0 5.0-7.5  0 12 35
BP178  2.5-5.0 2.5-5.0 2.5-5.0  0 3 25
BP134-cecropin A(25-37)      
BP188  2.5-5.0 1.25-2.5 2.5-5.0  10 24 42
BP215  1.25-2.5 2.5-5.0 2.5-5.0  0 3 14
BP190  5.0-7.5 >20 >20  11 17 32
a Xav, Xanthomonas axonopodis pv. vesicatoria; Pss, Pseudomonas syringae pv.
syringae; Ea, Erwinia amylovora
b Percent hemolysis plus confidence interval (α=0.05)
doi: 10.1371/journal.pone.0085515.t004
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Percent hemolysis at 50, 150 and 250 μM is shown in Tables 3
and 4.
Among the peptides of the first set, the two BP134
monomeric analogues BP199 and BP214 were not hemolytic
even at 250 μM (0-9%), whereas the dimer BP203 and the
trimer BP204 were highly hemolytic (95-100%) (Table 3).
Peptides incorporating an AGPA moiety either as a hinge or at
the C-terminus (BP192 and BP199-BP202) exhibited similar
hemolytic activity than the corresponding peptides that do not
incorporate this moiety (BP134, BP198, BP203, and BP204).
The incorporation of a KDEL moiety at the C-terminus of
BP134, BP193, BP195, BP201, BP202, and BP203 resulted in
peptides BP214, BP194, BP196, BP216, BP192, and BP198,
respectively, that did not display a clear hemolytic activity
pattern. The modification of the N-terminus of peptide BP202
with a Gly or a Ser residue led to peptides BP193 and BP195
with lower hemolysis (71-74% at 250 μM). In contrast, when
the same derivatization was performed on BP192, the resulting
peptides BP194 and BP196 were slightly more hemolytic
(74-92% at 250 μM). The presence of the epitope tag tag54-2
(not hemolytic) at the C-terminus of BP236 did not significantly
influence the hemolytic activity as compared to BP200 (92% vs
81% at 250 μM). Peptide dimer BP213, bearing a reversed
peptide sequence from BP134 at the C-terminus, was more
hemolytic (98% at 250 μM) than its analogue BP192 (69% at
250 μM). Peptide monomers BP199 and BP214 were the least
hemolytic sequences from this set (0-9% at 250 μM) and
BP192, BP193, BP195, BP196 and BP198 displayed <75%
hemolysis at 250 μM.
Regarding the second set of peptides (Table 4), the
combination of one unit of BP134 with melittin(10-19),
magainin(4-10) and magainin(1-10) resulted in analogues
BP170, BP180 and BP176, respectively, with a significantly
higher hemolysis percentage (58-98% at 250 μM) than that of
BP134 (18% at 250 μM). Among them, the most hemolytic was
BP170. Peptides containing an AGPA moiety as a hinge,
BP171, BP173, BP175, BP178, BP181, BP183 and BP215,
were less hemolytic (0-40% at 250 μM) than the corresponding
analogues BP170, BP172, BP176, BP179, BP180, BP182,
and BP188 (35-98% at 250 μM). The incorporation of a KDEL
moiety at the C-terminus of BP170, BP171, BP175, BP176,
BP180 and BP181 rendered peptides BP172, BP173, BP178,
BP179, BP182 and BP183 with similar or lower hemolysis.
When peptides BP171, BP175 and BP181 were modified at
the N-terminus with a Gly or a Ser residue, the resulting
sequences BP207-BP212 showed a comparable hemolytic
percentage being those incorporating a Ser residue the most
hemolytic. BP181 and its analogue BP235, incorporating a
BP134 unit and a magainin(4-10) fragment together with two
AGPA moieties and tag54-2, were not hemolytic even at 250
μM. Similarly to BP170, its analogues BP189 and BP217 were
highly hemolytic. The derivatives containing a BP134 unit and
a cecropin A(25-37) fragment, BP188 and BP190, displayed
similar hemolysis (42% and 32% at 250 μM, respectively). The
least hemolytic peptides from this second set are BP178,
BP181, BP183, BP209, BP211, BP212, BP215, and BP235
which displayed hemolysis ≤25% at 250 μM.
Phytotoxicity
All BP134 derived peptides were more phytotoxic than the
original monomer (Figures 1 and 2). However, phytotoxicity
was only observed at concentrations 10-to-50 times higher
than the MIC, as in the case of hemolytic activity. Tobacco
leaves responded in a very quick and selective manner to
peptides, and a clear dose-response effect was observed for
some of the best antibacterial peptides (BP134, BP209,
BP210, and BP211), with practically a linear increase from 50
to 250 μM (Figure 1). Melittin was the most phytotoxic peptide,
inducing lesions of around 2 cm diameter. The most phytotoxic
BP134 derivatives were BP214 (BP134-KDEL), BP192 and
BP213 (BP134 dimer derivatives), BP217 (BP134-
melittin(10-19) dimer derivative), BP178 (BP134-AGPA-
magainin(1-10)-KDEL), and BP188 (BP134-cecropin A(25-37)-
KDEL) (Figure 2). Peptides with moderate phytotoxicity were
BP100, BP173 (BP134-AGPA-melittin(10-19)-KDEL), BP183,
BP211, and BP235 (BP134-AGPA-magainin(4-10) derivatives),
BP209 and BP210 (BP134-AGPA-magainin(1-10) derivatives),
BP215 (BP134-AGPA-cecropin A(25-37)-KDEL), and BP216
(BP134 trimer derivative).
Relationship between phytotoxicity and hemolytic
activity
When phytoxicity was plot against hemolytic activity (Figure
2) two different patterns were observed. Peptides BP192,
BP213, BP216 and BP217 were strongly phytotoxic and
hemolytic, with similar values as melittin at the same
concentrations. In contrast, peptides BP173, BP178, BP183,
BP188, BP209, BP210, BP211, BP214, BP215, and BP235
were low or very low hemolytic but they unexpectedly caused
moderate to significant lesions in tobacco leaves upon
infiltration.
Discussion
The undecapeptide BP100 (KKLFKKILKYL-NH2), identified
from a library of cecropin A-melittin hybrid peptides, has
significant activity against X. axonopodis pv. vesicatoria, P.
syringae pv. syringae and E. amylovora (MIC of 2.5-7.5 μM)
and low hemolysis (22% at 150 μM) [17]. Since it is known that
peptide expression by plants requires a minimum chain length
and that these peptides are produced as C-terminal carboxylic
acids, here we describe BP100 analogues containing from 15
to 52 residues and a carboxylic acid group at the C-terminus.
The C-terminal carboxylic acid undecapeptide BP134
(KKLFKKILKYL-OH) was also included for comparison
purposes. In designing BP134 analogues, we incorporated
repeated units of BP134 or a combination of one BP134
sequence with a fragment of a natural antimicrobial peptide, in
particular, melittin(10-19), melittin(1-13), magainin(4-10),
magainin(1-10) or cecropin A(25-37). Moreover, we modified
these peptides by introducing one or two AGPA hinges as
stabilization/distortion moiety, a KDEL fragment at the C-
terminus as a signal for permanent retention of peptides in the
endoplasmic reticulum, a Gly or a Ser residue at the N-
terminus as a TEV protease recognition site and the epitope
tag KDWEHLKDWEHLKDWEHL (tag54) at the C-terminus for
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peptide detection and purification. We studied the influence of
these modifications on the antimicrobial and hemolytic
activities.
The combination of BP134 with another unit of this peptide
or with a fragment of melittin or magainin led to sequences with
higher antibacterial activity, being the hybrid BP134-
melittin(10-19) (BP170) the most active. Moreover, the
elongation of a peptide sequence with an AGPA hinge, a KDEL
unit or the tag epitope tag54-2 do not significantly influence
peptide activity. Notably, the modification of the N-terminus in
peptides BP171 (BP134-AGPA-melittin(10-19)), BP175
(BP134-AGPA-magainin(1-10)) and BP181 (BP134-AGPA-
magainin(4-10)) with a Gly or a Ser residue led to an increase
of the antibacterial activity. Peptides with this Gly or Ser
residue are generated upon hydrolysis with the TEV protease
over peptide-protein fusions in certain strategies for
heterologous expression in plants [38]. The resulting
sequences BP207-BP212 displayed similar activities and were
among the best peptides identified in this study (MIC of <1.25
to 5.0 μM). These results also show the effect of small
sequence modifications on the biological activity of these
peptides [17,42-44] and are in agreement with previous studies
reporting that the length and sequence are among the most
important factors for biological activity of antimicrobial peptides
[45].
The order of the peptide fragments is crucial for the
antibacterial activity. For example, the hybrid BP188,
containing the cationic peptide BP134 at the N-terminus and
Figure 1.  Phytotoxicity of selected antimicrobial peptides BP209, BP210 and BP211, in comparison to BP134 and
melittin.  Peptides were infiltrated in tobacco plant leaves at different concentrations (50, 100, 150 and 250 μM). The size of lesions
is considered as a measure of phytotoxicity. Peptide solutions at given concentrations were micro-infiltrated into the mesophyll of
leaves in plants and incubated for three days. Vertical bars within each column indicate confidence interval of the mean.
doi: 10.1371/journal.pone.0085515.g001
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the hydrophobic cecropin A(25-37) fragment at the C-terminus
is highly active against the three pathogens, whereas the
analogue BP190 containing cecropin A(25-37)-BP134 is only
active against X. axonopodis pv. vesicatoria and with higher
MIC values than BP188. This result is in agreement with the
structural features of cecropins necessary for antibacterial
activity which include a basic N-terminus and a hydrophobic C-
terminus [46].
Interestingly, the peptides incorporating a combination of a
normal and a reversed peptide sequence, like BP213 and
BP217, showed higher or similar activity than the normal
peptides BP192 and BP170, respectively. A similar behavior
has been previously reported for reversed peptides derived
from the antimicrobial peptides cecropin, melittin or magainin
[47-51].
Peptide toxicity has been evaluated against red blood human
cells thanks to the highly standardized methods available and
because data can be compared straightforwardly with other
reports, mainly dealing with human pathogens. In general, the
elongation of the BP134 sequence with another BP134 unit or
with a fragment of a natural antimicrobial peptide, produced an
increase of the hemolytic activity. The most hemolytic peptides
were those incorporating two BP134 units and those derived
from melittin(10-19) and melittin(1-13), while the derivatives
obtained from magainin and cecropin A fragments displayed
the lowest hemolysis. Among the latter, six peptides were less
hemolytic than BP134 (0-14% at 250 μM). The hemolysis
observed for the analogues designed from melittin, magainin
and cecropin A correlated with that of the natural peptides. In
fact, melittin has been described to be very cytotoxic for
erythrocytes, whereas magainin and cecropin A have no
toxicity [52,53]. Surprisingly, even though BP134 is low
hemolytic, the dimer BP203 and its analogues showed high
hemolysis.
Figure 2.  Relationship between the phytotoxicity of antimicrobial peptides and their hemolytic activity.  The assay was
performed at 50 (low, L), 150 (medium, M) and 250 μM (high, H). For some peptides not all concentrations were assayed.
doi: 10.1371/journal.pone.0085515.g002
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The incorporation of an AGPA hinge to peptides containing
two units of BP134 did not influence the hemolytic activity.
Notably, when this hinge was introduced in peptides including a
melittin, magainin or cecropin A fragment, the cytotoxicity
decreased significantly. The other modifications such as the
derivatization with a Gly or a Ser residue at the N-terminus or
with tag54-2 at the C-terminus resulted in peptides with
comparable hemolysis. Peptides bearing a Gly residue were
slightly less hemolytic than those containing a Ser. On the
other hand, the elongation of a peptide with a reversed
sequence afforded compounds highly hemolytic (BP213 and
BP217). Interestingly, the most active peptides BP207-BP211
showed low hemolysis (6-68% at 250 μM), being BP209,
BP210 (BP134-magainin(1-10) derivatives) and BP211
(BP134-magainin(4-10) derivative) the sequences with the best
balance between antibacterial and hemolytic activities.
In relation to phytotoxicity, all peptides were more phytotoxic
than BP134 and a dose-response direct relationship was
observed between the concentration of peptide and the
development of lesion in tobacco. However, best peptides in
terms of high antibacterial and low hemolytic activities (BP209,
BP210 and BP211) showed a moderate phytotoxicity. In
agreement with our observation is the report that the
constitutive expression of transgenes encoding certain BP134
analogues (BP192, BP213, BP216, BP217) has a negative
impact on rice plant regeneration upon callus transformation
[41].
Interestingly, several peptides incorporating a BP134 unit
and melittin, magainin or cecropin A fragment, showed low
hemolytic activity, but moderate or high phytotoxicity. It could
be possible that these peptides have no targets into the
erythrocyte membrane, but affect tobacco plant cell
membranes. However, a second possibility is that these
peptides are elicitors of the hypersensitivity reaction in tobacco
leaves, but this cannot be distinguished from phytotoxicity
based on lesion symptoms alone as used here, and would
require additional analysis. The possibility of having peptides in
the CECMEL11 library with defense elicitation properties is in
agreement with other studies reporting elicitation of defense
responses by peptides in BY2 tobacco cells and protoplasts
[54] and in cucumber and Arabidopsis leaves [55].
In the present work, phytotoxicity has been assessed by leaf
infiltration into tobacco as a model and it may differ in other
plant systems that can be used to express BP134 derivatives.
However, a significant correlation has been reported between
toxicity in tobacco leaves and rice seed germination for 10
relevant peptides (BP134, BP235, BP183, BP173, BP178,
BP215, BP217, BP213, and BP192) which have been included
in the present report [56].
In summary, we have described a convenient strategy for the
development of peptides to be expressed by plants with high
antibacterial activity, low hemolysis and moderate phytotoxicity.
The structural features that confer these biological properties
are the presence of an AGPA hinge together with a Gly residue
at the N-terminus as a protease recognition site. Moreover,
since the presence of a KDEL unit or tag54-2 at the C-terminus
of a peptide sequence do not influence significantly in its
biological activity, these moieties can be introduced enabling
the design of compounds that can be retained in the
endoplasmic reticulum and recognized by a complementary
epitope. Interestingly, the best peptides in terms of high
antibacterial and low hemolytic activities, with moderate
phytotoxicity were BP209, BP210 and BP211. Current
research by our laboratory involves the expression of several of
these peptides in rice plants using diverse strategies to direct
expression either to the whole plant or to seed endosperm or
embryo, that will permit to verify the main conclusions of the
present study.
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